Simplifying Global Compliance
Health Insurers Call for Greater FDA Authority
Washington Drug Letter
The FDA should have more power to force manufacturers to make labeling changes and conduct postmarketing clinical studies, a trade association of leading insurers said in recent recommendations.
To View This Article:
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing